Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and …
R Ferrari - Archives of internal medicine, 2006 - europepmc.org
Background Angiotensin-converting enzyme inhibitors reduce mortality and remodeling after
myocardial infarction in patients with left ventricular dysfunction. Methods Perindopril and …
myocardial infarction in patients with left ventricular dysfunction. Methods Perindopril and …
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study
P Jong, S Yusuf, MF Rousseau, SA Ahn, SI Bangdiwala - The Lancet, 2003 - thelancet.com
Background In the studies of left ventricular dysfunction (SOLVD), enalapril reduced
mortality in patients with symptomatic but not asymptomatic left ventricular systolic …
mortality in patients with symptomatic but not asymptomatic left ventricular systolic …
Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure
A Hognestad, K Dickstein, E Myhre, S Snapinn… - The American journal of …, 2004 - Elsevier
This retrospective, nonrandomized analysis evaluated the effect of initiating statin or β-
blocker treatment early in the course of heart failure developed during acute myocardial …
blocker treatment early in the course of heart failure developed during acute myocardial …
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
Background—Clinical trials in heart failure have focused on the improvement in symptoms
or decreases in the risk of death and other cardiovascular events. Little is known about the …
or decreases in the risk of death and other cardiovascular events. Little is known about the …
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement …
MA Pfeffer, E Braunwald, LA Moyé… - New England journal …, 1992 - Mass Medical Soc
Background. Left ventricular dilatation and dysfunction after myocardial infarction are major
predictors of death. In experimental and clinical studies, long-term therapy with the …
predictors of death. In experimental and clinical studies, long-term therapy with the …
Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular …
EL Knight, RJ Glynn, KM McIntyre, H Mogun… - American Heart …, 1999 - Elsevier
Background: Although angiotensin-converting enzyme inhibitor therapy reduces mortality
rates in patients with congestive heart failure (CHF), it may also cause decreased renal …
rates in patients with congestive heart failure (CHF), it may also cause decreased renal …
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled …
European Trial on Reduction of Cardiac Events with … - The Lancet, 2003 - Elsevier
BACKGROUND: Treatment with angiotensin-converting-enzyme (ACE) inhibitors reduces
the rate of cardiovascular events among patients with left-ventricular dysfunction and those …
the rate of cardiovascular events among patients with left-ventricular dysfunction and those …
Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and …
DL Dries, MH Strong, RS Cooper… - Journal of the American …, 2002 - jacc.org
Objectives: This study was undertaken to determine whether enalapril had comparable
efficacy in black and white patients with asymptomatic left ventricular dysfunction (ALVD) in …
efficacy in black and white patients with asymptomatic left ventricular dysfunction (ALVD) in …
Angiotensin–neprilysin inhibition versus enalapril in heart failure
Background We compared the angiotensin receptor–neprilysin inhibitor LCZ696 with
enalapril in patients who had heart failure with a reduced ejection fraction. In previous …
enalapril in patients who had heart failure with a reduced ejection fraction. In previous …
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
Background Half of patients with chronic heart failure (CHF) have preserved left-ventricular
ejection fraction (LVEF), but few treatments have specifically been assessed in such …
ejection fraction (LVEF), but few treatments have specifically been assessed in such …